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ABSTRACT
The fatigue and cognitive performance deficits associated with sleep loss and stress, like that
experienced during sustained flight operations and nighttime flying, have motivated the search for effective
nonpharmacological countermeasures. The behavioral effects of the potential countermeasure tyrosine, an
amino-acid precursor to dopamine and norepinephrine, were examined during an episode of continuous
nighttime work involving one night's sleep loss. Volunteers performed nine iterations of a battery of cognitive
and subjective tasks for approximately 13 h, beginning at 1930 and ending at 0820 the following morning.
Subjects temained awake throughout the day on which the experiment began and were awake for approximately
24 h by the end of testing. Six hours after the start of the experiment, one-half of the subjects received 150
mg/kg tyrosine in a split dose while the other half received a cornstarch placebo in a double-blind procedure.
The tracking-task performance of tyrosine subjects declined less during the night than that of placebo subjects.
Tyrosine administration was also associated with nonsignificant trends toward reducing a) lapses on a high-
event-rate vigilance task, b) subjective sleepiness, and c) the intensities of several fatigue-related symptoms. In
all these cases, the improvements were short-lived, never lasting more than two consecutive testing sessions and
disappearing by the last testing session. The results of this study suggest that tyrosine is a relatively innocuous
substance and, after further testing with other doses and administration schedules, may prove useful in
counteracting performance decrements during episodes of sustained work coupled with sleep loss.
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INTRODUCTION
Naval aviation is an inherently stressful, demanding, and dangerous occupation. Naval aviators face
the challenges of flying complex aircraft for long durations and in all varieties of weather. Carrier-based
aviators must launch and recover on small, pitching and rolling flight decks. Flying performance and the
probability of mission success are enhanced by well-rested, unstressed crews operating at peak alertness.
Unfortunately this is not always the case, even in peacetime, due to the frequent requiremenk of flying at night.
Flying at night is more challenging than flying during the day because the reduction in perceptual information
that occurs in the dark leads to increased reliance on instruments. This can transform an ordinary mission into a
high-task-load situation at a time when the body is fatigued and the natural tendency is to sleep. Because
aircrew are rarely physiologically adapted to a nighttime work and daytime sleep schedule, the problems of
night flying, like those of the night shift work, are significant and real.
Perhaps the most negative consequence of nighttime flying is the misalignment that occurs between the
sleep-wake schedule and the phase of the circadian pacemaker. In other words, an aviator must attempt to
remain awake and alert during a night flight at a time when intrinsic circadian rhythms are operating to promote
sleep. Later, after returning to the carrier, the aviator must attempt to sleep during the day when the pacemaker
is operating to promote wakefulness. .ivilian, night shift workers who routinely live and work in this state of
misalignment experience many negative health and performance aftereffects (Monk & Folkard, 1992). Another
problem of nighttime flying is the inevitable sleep deprivation that accompanies it. Aviators flying at night must
operate on a schedule that would have them sleeping if they were not flyinag. There are few opportunities to
lessen the impact of impending sleep loss with prophylactic naps or sleep-wake schedule manipulations before a
night flight. Sleep duration is often sacrificed, Finally, aviators may begin night missions usually after being
awake the entire day (15-18 h). This situation contrasts with that of daytime flying when aviators can launch
fresh and alert after a full night's sleep. These perceptual and sleep-related problems combine to make flying at
night more challenging and risky than flying during the day.
Circadian and sleep-related problems of misalignment, sleep loss, and shortened sleep duration increase
the probability of fatigue, The adverse consequences in con.. itive performance of forgoing sleep while working
at night have been well documented in laboratory studies (see Dinges & Kribbs, 1991; Hockey, 1986; Holding,
1983; Johnson, 1982; Tilley & Brown, 1992, for reviews). Perhaps the most notable effects of sleep
deprivation and fatigue are brief episodes of sleep (*microsleeps") that lead to lapses in responding in cognitive
and perceptual tawks (Bills, 1931; Patrick & Gilbert, 1896; Warren & Clark, 1937; Williams, Lubin, &
Goodnow, 1959). Although lapses may represent the most visible and profound effect of sleep deprivation, a
number cf investigators have suggested that sleep deprivation may lead to a gene-alized slowing of responses as
well (Dinges & Kribbs, 1991; Kjellberg, 1977; Lisper & Kjellberg, 1972; Tharp, 1978; Williams et al. 1959).
Regardless of the exact form these deficits take, any increase in lapses, slowing of response times, or other
cognitive decrements occurring in naval aviators flying at night could letd to failures to correctly perceive and
respond to critical visual and auditory events. In combat aviation, these failures can translate into failures to
detect dangerous or unsafe conditions in the cockpit as well as potential ta. * utside the cockpit.
Furthermore, when coupled with sleep loss, the periods of boredom that often occur while on patrol, during
return flights from combat, or d&ring transoceanic flights can make microsleeps and lapses even more frequent.
Overlaid on the fatigue frorn flying at night end occasional boredo.m during uneventful patrols, is the
transient but significant stress associated with carrier launches, critical periods of the mission (especiaily in
combat), and carrier recoveries. Nighttime recoveries are more challenging and dangerous than daytime ones
and therefore are inherently more stressful. High-stress levels have been associated with elevated levels of
urinary catecholamina's, rnflecting increased secretion (Stone, 1975). This catecholamine secretion is considered
part of a generalized stress response. Sleep deprivation appears to be similar to other stressors; the ensuing
fatigue is nonspecific and is similar to other stress responses (Craig & Cooper, 1992). This view suggests that
sleep deprivation could lead to increased catecholamine secretion, and eventually a selective reduction of
catecholamineas in the brain. The view that sleep deprivation is a stressor like any other, in terms of
catecholamine secretion, is not universal (Froberg, Karlsson, Levi, & Lidberg, 1972). ,owever, there is
agreement that sympathoadrenal activity is altered with sleep deprivation when the deprivation is accompanied
by demanding tasks (Craig & Cooper, 1992). With a heavy task load, sleep-deprived individuals may increase
their level of stress by expending extra effort in an attempt to overcome fatigue-indu ced cognitive impairment.
During nighttime flying, naval aviators experience a unique combination of demanding task activity and sleep
loss, resulting in fatigue, stress, and possibly essential catecholamine reduction.
Given that nighttime flying is an operational necessity, what can be done to counteract the
consequences of fatigue and stress? There are two general approaches. One approach uses pharmacological
agents to enable the body to overcome the cognitive effects of fatigue by improving reaction times, reducing
memory deficits, decreasing response lapses, and boosting alertness and mood. Several applied studies have
shown that a variety of stimulants are effective in small doses, with a relatively small risk of physiological or
behavioral side effects (Babkoff, Kelly, Matteson, Gomez, Lopez, Hauser, Naitoh, & Assmus, 1992; Johnson,
Spinweber, Gomez, & Matteson, 1989; Newhouse, Penetar, Fertig, Thorne, Sing, Thomas, Cochran, &
Belenky, 1992; Shappell, Ned, & DeJohn, 1992; Stanny, McCardie, & Ned, 1993a, 1993b). These alerting
substances may have a role in naval aviation under well-defined circumstances--after the prescreening of aviators
on the ground, with the consent of appropriate commanders, under the close supervision and control of the flight
surgeon, and with the voluntary consent of the aviator.
In many circumstances, however, a pharmacological countermeasure is inappropriate. Therefore, the
use of nonpharmacological countermeasures constitutes an alternative approach. Numerous nonpharmacological
countermeasures are available, including exercise (e.g., Angus, Heslegrave, & Myles, 1985; Englund, Ryman,
Naitoh, & Hodgdon, 1985), napping and sleep logistics (e.g., Angus, Heslegrave, Pigeau, & Jamieson, 1987;
Mullaney, Kripke, Faeck, & Johnson, 1983; Naitoh & Kelly, 1992), light manipulation (e.g., Competatore,
1993; Kelly, Smith, & Naitoh, 1989), and dietary manipulations (e.g., Lieberman, Corkin, Spring, Growdon, &
Wurtman, 1983; Lieberman, Corkin, Spring, Wurtman, & Growdon, 1985; Wurtman, 1982). Amino acids, in
particular, have generated much interest and controversy regarding their effects on health and performance
(Braverman, 1987; Dean & Morgenthaler, 1990). Tyrosine is one amino acid that has received recent attention
as a potential countermeasure to stress (Ahlers, Salander, Slmrtleff, & Thomas, 1992; Owasoyo, Neri, &
Lamberth, 1992; Salter, 1989; Shurtleff, Thomas, Ahlers, & Schrot, 1993; Wurtman, 1986). Tyrosine is a
large, neutral amino acid found in dietary proteins. It is a precursor of the catecholamines dopamine and
norepinephrine. Should the fatigue of sleep deprivation be stressful enough to result in significant brain
catecholamine reduction, making tyrosine available might serve to increase catecholamine synthesis and thereby
improve mood and performance. A more detailed description of the biochemistry and physiological role of
tyrosine, a review of its effectiveness in animals and man, and a fully-developed rationale for its use in military
operations involving sleep loss arc presented elsewhere (Owasoyo et al., 1992).
In addition to the potential benefit of tyrosine from increased catecholamine synthesis, the amino acid
may also serve to assist in fighting fatigue indirectly. Tyrosine competes with other large, neutral, amino acids
for transportation from blood to brain. The amount of tyrosine that enters the brain depends on the amount
available relative to the sum of the other available amino acids (the tyrosine ratio). Elevating the tyrosine ratio
by ingesting tyrosine may increase the anount of tyrosine that enters the brain at the expense of other competing
amino acids such as tryptophau (Wurtman, Hefti, & Melamed, 1981). Tryptophan, a sleep promoter
(Braverman, 1987), is a precursor of serotonin, which in turn is a precursor of melatonin. Melatonin also has
known sleep-inducing effects (see Kelly et al., 1989, for a review). Tyrosine ingestion may reduce the levels of
available tryptophan, limiting melatonin synthesis, and thereby indirectly reducing fatigue.
Previous studies of the effectiveness of tyro',"D in counteracting stress and fatigue in humans have
yielded mixed results. Tyrosine was found effective in counteracting adverse behavioral effects resulting from
both cold (Shurtleff, Thomas, Schrot, Kowalski, & Harford, 1994) and cold plus hypoxia in subjects most
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affected by these stressors (Banderot & Lieberman, 1989; ). However, it failed to prduce mersurable effects
on mood and performance in both rested (Lieberman et al., 1985) and sleep-deprived subjects (J. French,
personal communication, October 1993). The inconclusive nature of these findings, along with tyrosine's
established role as a precursor to the catecholamines, its possible role in decreasing brain levels of tryptophan,
and its relative safety make it worthy of further study as a countermeasure to fatigue and stress. The present
study examined the effects of tyrosine on cognitive performance and subjective fatigue during a period of
sustained wakefulness involving the loss of one night's sleep.
MATERIALS AND METHODS
SUBJECTS
Twenty male, U.S. Marines, ranging in age from 21 to 27 years (M - 24.5) and ranging in weight
from 66.66 kg to 99.34 kg (M - 80.36) volunteered for the experiment. All were college graduates awaiting
initial flight training. The subje-ts had current flight physical examinations and underwent medical screening by
a flight surgeon before the experiment. Subjects wer- fully informed as to the purpose of the experiment and
were told that they would receive either tyrosine and a placebo. Subjects were also informed that they were
free to withdraw any time dilring the experiment without prejudice.
APPARATUS
All cognitive performance and subjective tasks were administered on six, Intel 486DX/33-based IBM
PC-compatible desktop computers equipped with Panasync 1381i SVGA color displays, Microspeed PC-Trak
trackbills, and Systems Research Laboratory Labpak input-output modules with DigiTalker speech synthesis
cards. Auditory stimuli were presented using Koss Pro 4AAA Plus headphones. The computers were linked by
an Artisoft, Inc., LANtastic local-area network.
INSTRUMENTS
Three computer-administered objective performance tasks and two computer-administered subjective
measurua were performed repeatedly by the subjects throughout the experiment. Several physiological measures
were also obtained at regular intervals. Each measure is described ;n aetail below.
Compensatory tracking task. The compensatory tracking task is a measure of eye-hand coordination.
It reqaire. the subject to maintain the position of a small airplane-shaped cursor at the intersection of a large set
of cross-hairs located in the middle of the video display. The cursor was manipulated using the trackball.
Rolling the trackball away from the subject moved the cursor toward the bottom of the screen whereas mtling it
toward the subject moved the cursor toward the top of the ac, ne. Left and right movements of the trackbell
resulted in coresponding left and right movements of the cursor'. When not controlled by the trackball. the
cursor continually drifted away from the center of the screen in a random direction. Thus. continuous
movements of the trackball by the subject were required to compensate for the drift in the cursor. Task
duration was 10 min.
High-event-rate vigilance task (running memory). The running memory task is a variant of the
Continuous Performance Task (Rosvold, Mirsky, Samson, Bransame, & Beck, 1956) teed by Willisms ot al.
'This pattern of movement was chosen to mimic the type of control provided by an aircraft's flight stick,
with forward movement of the stick resulting in a downward movement of the aircraft's nose and backward
movement of the stick resulting in an upward movement of the nose. Such coupling between trackboll and
cursor is similar to controlling a remote vehicle or drone.
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(1959) in their seminal analyses of the performance of sleep-deprived subjects on experimenter-paced tasks.
The running memory task requires subjects to monitor a randomly ordered sequence of the upper case letters,
"A" through "Z," presented individually for 50 ms in the center of the video display. The interstimulus interval
was 1250 ms, measured from stimulus onset to stimulus onset. Subjects were required to decide whether each
leter matched the immediately preceding letter in the sequence. A random 50% of all letters matched the
imme!i,.ely preceding one. Subjects responded by pressing a key with the first finger of one hand whenever a
letter matched its immediate predecessor and another key with the first finger of the other hand when a letter
differed from its immediate predecessor. Key assignments to dominant and nondominant hands were
counterbalanced across subjects. A total of 480 stimuli was presented in each block of trials, requiring
approximately 10 min to complete.
Dichotic listening task (DLT). The DLT (Gopher & Kahneman, 1971) required subjects to identify
and recall, in order, "he numbers in a sequence of II letters and 5 numbers presented in a synthesized voice to
one ear. The subjects were required to ignore a competing sequence of letters and numbers presented
simultancously to the opposite eat. At the beginning of each trial, a 500-ms, 1000-Hz tone was presented over
both headphones as a ready stimulus. After a 1200-ms delay following the onset of the ready stimulus, the ear
to which the subject was to attend was indicated by presenting the word "Left" or *Right" over both
headphones, After a further 800-ms delay following the onset of the word "Left or "Right," a sequence of I I
letters and 5 numbers was delivered to the target ear. The letters used were A-Z except W: the numbers used
were 0-9. The order of the letters and numbers was randomrizxd. As the letters and numbers were being
delivered to the target ear, a different random swquence of I I letters and 5 numbers was delivered to the
nontarget ear. Whenever a letter was poresnted to one ear, a different etter was presented to the opposite ear.
The letter delivered to the nocauget ear was. coo.si•ramd not to rhyme with the letter being presented to the
target ear. Whenever a number was presented to one ear, a different number %as presented to the other ear.
The intermals betvcen the onsets of the kiter-number stimuli wre 700 ms. The subject was told to ignore all
letters presented to the target ear and all letters and numbers preserntcd to the noxtarget ear. At the end of each
sequence, five u rscore marks appeared on the .tdeo d,.pltay. Subects resned by typing the numbers
heard in the target ear in order. on the compuker ke' board. This cAused the typed numbers to appear above the
underscore Mares on the dIspIa). Sub.tsU, w ri, alk<r,'ed 6.25 s to type their responss 'and correct errors
before the next triai began. A toail of 48 stimuluts .seutene were pre-ented in emch bock of trials. Each
sequence was approismately 19 45 s in duraliom. Ahich -ielded a task duration of approximately 15.56 min.
Visual Analog Scak (VASo The VAS allows for the asestnent of a custornuzed .wt of hbjective
symptoms. Ma states (De.John. Mart. Mlin.a. Mtcadit, 1992) A squ.aece of adjectovs (sympornms) appeared
one at a time on the di-T.ay aho-we a ho.itntal line segment The lih of symptoms ts included as Appendix A.
The hoon im lne ws Labeled with '0' at the heft end AM * 100 at the nght. Subjects %ere instructed that *0"
corresponded to no senwton of the symptom. &hslv 100" corre-spomded to the moss intense symptom sensation
imaginable. An arrow, appeared an the muddle of the ds-tVay below the lan The 1 hsubjet' task was to move the
arrow, using the tr-akball. to the psition (xn the line that coffc.4,oxded to the intencnt'w of the symptom
expenenced at that monnent Th tA.sk requrrd ap•r,,%arAuely 3 5 min to complete
"Stanford Sleepiws S&ale (SSS). The 55.S (Ihxlddes. DIfment. & Zarcotae. 1971; i-,oddes, Zarcone,
Smythe. Phillips. & Denmrit. 1973) %aws used to asswms subjects' slecpness levels througlhout the experiment.
"This scale, reproduced in Appcndix 8, Appeared on the %.ideo display. Subjects entered on the keyboard the
number of the sleepinm.s des.nuption that mosst clo•el, co~rrponded to how they felt at that aciomnent. The task
usually took less than 30 s to complete
Post-study questionnaire. The post-study que-stionnaire was a paper-and pencil survey consisting of
several questions regarding ste%.p latcn.,, and qualit), and a question concerning whether the subject believed he
had received tyrosine or the placebo.
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Physiological measures. Body temperature, systolic and diastolic blood pressure, and htfart rate were
monitored and collected throughout the experiment. Body temperature was measured using an I'AC digital oral
thermometer. Blood pressure was assessed with standard Marshal sphygmomanometers and stethoscopes. Heart
rate was monitored using Escort electrocardiogram telemetry units.
PROCEDURE
Testing environment. The experiment was carried out in the Sustained Operations Laboratory of the
Naval Aerospace Medical Research Laboratory. The Sustained Operations Laboratory is a large windowless
room configured with six subject workstations and a monitor's console. Each work station was separated from
the others by a large partition, which prevented subjects from observing each other during testing. At each
workstation was a computer, configured as described above. The laboratory was dimly lit by ceiling-mounted
incandescent lights positioned so that illumination glare would rnot interfere with the perception of the video
displays.
Training. Subjects trained on the computer tasks over a 4-d period, beginning Monday morning and
ending Thursday morning. Training consisted of eight sessions, each lasting approximately 40 min. The
presentation order of the computer tasks was VAS, SSS, tracking, running-memory, and DLT, By the end of
training, subjects had completed eight VAS and SSS measures, eight 10-min tracking sessions, 3,840 running
memory trials, and 384 DLT trials.
Testing. Subjects were run in groups of 4, 6, 3, 4, and 3, with subjeits in both tyrosine and placebo
conditions participating in each session. The experiment began on the Thursday evening following the
completion of training. Conditions during the experiment were the same as during training, with the following
exception. During the experiment, subjects were exposed to a moderate intensity (70-dB A), low-frequency
(150-Hz cutoff) noise that resembled the muffled rumble of a jet aircraft engine. The noise was employed as a
realistic environmental stressor at a sound intensity selected to be low enough to avoid arousal effects. The
noise was omitted during training to ensure that subjects could concentrate fully on learning the cognitive tasks.
Testing began at 1930 Thursday and proceeded until 0820 Friday morning. The order and duration of
tasks and breaks within each 90 .min experimental block are shown in Table 1. Subjects completed nine blocks
of tasks during the experiment. During the short (5-mmn) break,-, subjects were allowed to stand and use the
bathroom. During the long (40-min) breaks, body temperature, blood pressure, and heart rate were recorded
and subjects were provided caffeine-free snacks. Subjects were restricted to the laboratory and an adjacent
corridor during the experiment.
Tyrosine (Ajinomoto Company, Inc.) was simultaneously administered to 10 randomly selected subjects
during the long breaks that followed the fourth and fifth testing blocks (i.e., at 0130 and 0300). At both times,
tyrosine was administered in doses of 75mg/kg of body weight, resulting in a total administration of 150mg/kg.
This dose was chosen because previous work in humans has shown 100-150 mg/kg to increase the plasma
tyrosine ratio two- to threefold (Glaeser, Melamed, Growdon, & Wurtman, 1979). Tyrosine was administered
in a split dose because its half-life is relatively short, at 2-3 h (A. Dollins, Massachusetts Institute of
Technology, personal communication, July, 1992). Two smaller, spaced doses would therefore serve to
maintain plasma levels for a longer time. Ten randomly selected subjects in the placebo group receivd
150mg/kg of cornstarch. The cornstarch, like the tyrosine, was divided into two doses and administert,.d during
the long breaks following the fourth and fifth testing sessions at 0130 and 0300, respectively. Cornstarch was
chosen as the placebo because it is a relatively inert and tasteless substance. Each dose of cornstarch or tyrosine
was mixed with approximately 113 g of banana-flavored yogurt and administered to the subjects in a double-
blind procedure. Previous testing with research staff indicated that cornstarch mixed with 113 g of banana
yogurt is indistinguishable in taste, texture, and appearance from tyrosine mixed with the same quantity of
banana yogurt.
Table 1. Experimental Task Order and Duration (min).
Test Duration Cumulative duration
VAS/SSS 04 04
Tracking 10 14
Break 05 19
Running memory 10 29
Break 05 34
DLT 16 50
Break 40 90
After completing the final testing session, subjects were asked to rest (and, if possible, sleep) for 6 h in
the .aboratory dormitory. At the end of this post-experiment recovery period, each subject filled out the
post-study questionnaire and received a final medical screening by a flight surgeon.
RESULTS
Tests of significance were performed using split-plot analyses of variance (ANOVAs) with drug
treatment (tyrosine or placebo) as the between-groups factor and time (nine test administrations) as the repeated
factor. The significance levels of repeated-measures F ratios with two or more numerator degrees of freedom
were corrected for nonsphericity effects using the procedure of Huynh and Feldt (1976).
PERFORMANCE MEASURES
Compensatory tracking. The Euclidean distance (in pixels) between the cursor and the center of the
cross-hair was measured continuously. The root-mean-squared (RMS) value of this distance was calculated at
1-min intervals. The first minute of each tracking session was treated as a task-adaptation period; the RMS
values from minutes 2-9 were averaged to produce a global tracking score.
Figure 1 shows tracking performance versus time in the placebo and tyrosine groups. Lower RMS
error scores correspond to better performance. Tracking performance in both groups can be seen to decrease
steadily during the night. Averaged across both groups, the reduction in performance with time was highly
significant, F(8, 144) = 21.29, p < .0005. A1 Fig. 1 indicates, the two groups performed at similar levels
during the trials before tyrosine was administered. Following tyrosine administration, the placebo group's
performance continued to worsen. Although the tyrosine group's performance also wursened, the performance
of the tyrosine group declined much less than that of the placebo group and remained better than that of the
placebo group until the final test block. This separation in performance resulted in a significant Groups x Time
interaction, F(8, 144) = 2.99, p = .04. Analyses of the simple main effects associated with this interaction
revealed that the difference in tracking scores between groups was significant at 0439 h, F(I, 18) = 4.46,
p = .049, and 0606 h F(1, 18) = 4.47, p = .043. No other between-groups differences were found.
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Figume 1. Root-mean-squared (RMS) tracking error versus time in pursuit tracking. A rrows indicate
administration times.
Running memory. Three scores were computed for the running memory task. The first score,
proportion of correct responses, P(C), was the sum of the number of correct responses divided by the number of
responses made during the block. The second score, reaction time (RT), was the average time (in milliseconds)
required to make a correct response. The last score, the proportion of lapses or nonresponses, P(N), was the
proportion of stimuli to which subjects failed to respond during the 1250-ms interval available for responding.
Each run'ring-metmoty dependent measure was analyzed using the ANOVA model described previously.
The P(C) analysis revealed a significant main effect of Time, F(8, 144) = 18.50, p < .00005. The RT
analysis also indicated the piesence of a significant effect of Time, F(8, 144) = 20.36, p < .00005. An
examination of group means revealed that P(C) decreased steadily during the night while mean RT increased.
No significant differences between treatment groups were found in either P(C) or RT.
ilgure 2 shows P(N) versus time. In both groups, the proportion of lapses increased systematically
during the night. This overall increase in lapses, averaged across groups, was highly significant,
F(8,144) = 17.46, p < .00005. Nonresponses were very similar across groups through 0154 h. As in tl-e
tracking task, there was a noticeable separation of the tyrosine- and placebo-group means at 0454 and 0624 h.
In this case, however, the differences at 0454 and 0624 failed to reach significance.
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FIgure 2. Nonresponse probability (P(Nonresponse)) versus time in running memory. A trows indicate
administration times.
Dichotic listening task. Two scores were calculated for the DLT. The first score, P(C), was the
proportion of trials in which all items in the string were recalled in correct order. The second score, the
proportion of nonresponses, P(N), was the proportion of trials on which subjects failed to respond during the
allotted 6-s response interval.
Figwue 3 shows P(C) versus time in the LILT for the placebo and tyrosine groups. In both groups,
performance remained high during the first few hours of testing. By 0042, however, performance in both
groups had declined noticeably. Performance continued to decline, reaching a minimum at 0642, and then
improved in the finai block of trials. The ANOVA revealed that the effect of time on performance was
significant, F (8, 144) = 30.40, p < .005. No significant between-group effects were found. Analyses
performed on P(N) revealed a similar pattern of results.
o Placebo
* Tyrosin.
00.00
60.00
W7.00I 0.00
5O..i0 i---.
10.00 1
Thme of Day
FIgum 3. Pertentage coirect responses verses time in Dichotic Listening. A rrows indicate administration times.
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SUBJECTIVE MEASURES
Stanford Sleepiness Scale. Figure 4 shows the SSS ratings versus time in the placebo and tyrosine
groups. Sleepiness ratings increased steadily during the night. This effect of time on sleepiness ratings was
highly significant, F(8, 144) = 84.30, p < .0005. Mean sleepiness ratings were similar for the tyrosine and
placebo groups through 0434 . As with tracking efficiency and running-memory lapse probability, group
sleepiness ratings differed slightly between 0434 and 0604. The tyrosine group's sleepiness ratings remained
stable during these two sessions, in contrast, the placebo groups's sleepiness ratings continued to increase.
Consequently, the mean sleepiness rating in the tyrosine group was lower by one step on the scale than the mean
rating in the placebo group at 0604. These effects, however, failed to reach statistical significanci,.
o Placebo
* Tyrosine
Almost in . - . . .Reverie
sleep
Not At Full -C Alertuess
Not at
Pe=
Active _i
Time of Day
Figure 4. Stanford Sleepiness Scale ratings versus time. Arrows indicate administration times.
Visual Analog Scale. Table 2 is a list of symptoms that were significantly affected by time. The
pattern of results fob the VAS resembled that for the SSS shown in Fig. 4. The tyrosine and pl..cebo groups
showed a similar pattern of responses on the VAS until the seventh and eighth sessions (0403 and 0600,
respectively). At that time, the tyrosine group reported less fatigue, boredom, and depression, and more
attention and alertness than the placebo group. However, none of these between-groups differences reached
statistical significance.
Post-study questionnaire. Subjects' responst.s on the post-study questionnaire indicated that
they were unable to reliably guess which substance thty had received. Forty percent of the subjects in the
tyrosine group correctly guessed that they had received the substance whereas twenty percent of the subjects in
the placebo group guessed that they had received tyrosine, X2 (I, N = 20) < 1.0. There were no significant
differences between groups in responses to items related to sleep latency, sleep quality, or the need for more
sleep on awakening.
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Table 2. VAS Symptoms Significantly Affected by Sustained Wakefulntss.
Symptom Direction of change from first to last Block
Fatigue Increase
Boredom Increase
Sleepiness Increase
Depression Increase
Headache Increase
Hostility Increase
Restlessness Increase
Alertness Decrease
Attention Decrease
Euphoria Decrease
Talkativeness Decrease
PHYSIOLOGICAL MEASURES
The results of the ANOVAs performed on mean systolic and diastolic blood pressure revealed no
significant changes attributable to time or tyrosine treatment. There were significant main effects of time for
mean oral body temperature and mean pulse rate, F (8, 144) = 22.59, p = .005, and F(8, 144) = 6.52,
p < .0005, respectively. An examination of group means revealed that body temperature and pulse rate
steadily decreased during the night. No between-groups differences in oral body temperature or pulse rate were
found,
DISCUSSION
Performance on the three cognitive tasks employed in this experiment declined steadily throughout the
course of the night. These results are consistent with those from other sleep-deprivation studies reviewed by
Dinges & Kribbs (1991) and Tilley & Brown (1992). Specifically, decreases in psychomotor performance,
vigilance, and auditory attention, and increases in RTs and response lapses were observed. Thus, the
experimental paradigm successfully induced levels of fatigue high enough to produce measurable performance
decrements. Accompanying the performance decline were substantial increases in subjective sleepiness and
fatigue and a decrease in subjec'ive alertness and attention.
Tyrosine administration was associated with a significantly smaller performance decline in the tracking
task. Tyrosine also yield4 nonsignificant trends in the direction of reduced lapses in the running memory task,
reductions in subjective sleepiness, and reductions in the intensities of several fatigue-related symptoms. In all
these cases, the improvements were short-lived, .iever lasting more than two consecutive testing sessions and
disappearing on all tasks by the last testing session. Additional doses of tyrosine would be necessary to
determine whether the slowing of the performance decline could be extended throughout the period of enforced
wakefulness. These data suggest that, for any behavioral effects of tyrosine to be sustained, it might be
necessary to administer the substance repeatedly during continuous work episodes. The effects of tyrosine on
tracking, lapses, and sleepiness ratings occurred approximately 1.5-2.0 h after the second administration and
appear to have lasted only a few hours. The timing and brief duration of these possible effects are consistent
with the view that the half-life of tyrosine is relatively short.
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Several factors might account for the modest effects of tyrosine on the performance indexes other than
tracking error. First, the physiological effects of the continuous-work manipulation, although sufficient to
impair performance and mood, may nevertheless have been too small to significantly reduce brain catecholamine
levels. Feedback mechanisms evidently buffer catecholamine-transmitter supplies against fluctuations in
precursor levels (see review by Wurtman et al., 1981). Conditions that deplete the transmitter reserves of
catecholaminergic neurons, notably high rates of impulse activity, are associated with increases in the conversion
of tyrosine to norepinephrine. A longer period of sleep deprivation, perhaps with addition~l stressors, might
deplete catecholamine transmitters sufficiently that increases in tyrosine would yield increases in catecholamnine
synthesis and, thus, improvements in mood and performance. Second, the tyrosine dose(s) used in the present
experiment may simply have been too low or administered too infrequently to be effective. Higher doses
administered over longer periods might produce stronger and longer-lasting effects. Third, some of the tasks we
used may have been too insensitive to detect effects of tyrosine on performance. This seems possible, inasmuch
as the effects of food constituents on performance tend to be subtle and difficult to demonstrate empirically
(Lieberman et al., 1983). More subjects might be required to obtain adequate power with these tasks.
Nonetheless, the findings do indicate that tyrosine had a significant effect on a psychomotor task of
substantial relevance to aviation. Indeed, in some circumstances, the apparently brief duration of the effect may
afford advantages relative to those of longer-acting stimulants, such as the amphetamines. Amphetamines can
potentially interfere with the onset, duration, and quality of sleep (Hart & Wallace, 1975; Hartmann & Cravens,
1976), even after substantial sleep deprivation (Newhouse et al., 1989; Penetar et al., 1991). There was no
indication that tyrosine interfered with subjects' recovery sleep in this study. Of additicaal importance, tyrosine
did not produce any physiological side effects. In contrast to results obtained in continuous-performance studies
of d-amphetamine (Newhouse, Belenky, Thomas, Thorno, Sing, & Fertig, 1989) and d-methamphetamine
(Stanny et al., 1993a), tyrosine did not increase heart rate or blood pressure; nor did it significantly alter oral
body temperature. None of the subjects reported any negative feelings or symptoms attributable to tyrosine
administration.
In conclusion, the results of this study, though mixed, are promising. They suggest that tyrosine is a
relatively innocuous substance that might prove useful in counteracting performance decrements during episodes
of sustained work coupled with sleep loss. Further studies are needed to determine whether tyrosine's effects
might be enhanced under more stressful conditions andior with different doses and timing of administration.
11
REFERENCES
Ahlers, S.T., Salander, M.K., Shurtleff, D., & Thomas, J.R. (1992). Tyrosine pretreatment alleviates
suppression of schedule-controlled responding produced by corticotropin releasing factor (CRF) in rats.
Brain Research Bulletin, 29, 567-571.
Angus, R.G., Heslegrave, R.J., & Myles, W.S. (1985). Effects of prolonged sleep deprivation, with and
without chronic physical exercise, on mood and performance. Psychopharmacology, 22, 276-282.
Angus, R.G., Heslegrave, R.J., Pigeau, R.A., & Jamieson, D.W. (1987). Psychological performance during
sleep loss and continuous mental work: The effects of interjected naps. In Sleep and its implications
for the military, Lyon, France, Mar 16-17 Ontario, Canada: Defence and Civil Institute of
Environmentil Medicine.
Babkoff, H., Kelly, T.L., Matteson, L.T., Gomez, S.A., Lopez, A., Hauser, S., Naitoh, P., & Assmus, J.
(1992). Pemoline and methylphenidate: Interaction with mood, sleepiness, and cognitive perfor.nance
during 64 hours of sleep deprivation. Military Psychology, 4, 235-265.
Banderet, L.E., & Lieberman, H.R. (1989). Treatment with tyrosine, a neurotransmitter precursor, reduces
environmental stress in humans. Brain Research Bulletin, 22, 759-762.
Bills, A.G. (1931). Blocking: A new principle in mental fatigue. American Journal of Psychology, 43,
230-245.
Braverman, E.R. (1987). The healing nutrients within. New Canaan, CT: Keats Publishing.
Comperatore, C.A. (1993). Using controlled daylight exposure and sleep timing In the prevention qf shift lag
during night operations (USAARL Report No. 93-25). Fort Rucker, AL: U.S. Army Aeromedical
Research Laboratory.
Craig, A., & Cooper, R.E. (1992). Symptoms of acute and chronic fatigue. In A.P. Smith & D.M. Jones
(Eds.), Handbook of human performance. Vol. 3. State and trait (pp. 289-339). London: Academic
Press.
Dean, W., & Morgenthaler, 1. (1990). Smart drugs & nutrients. Santa Cruz: B&J Publications.
DeJohn, C.A., Marr, M.d., Molina, E.A., & McCardie, A.H. (1992). A computer-based visaal analog scale
(Tech. Memo No. 92-1). Pensacola, FL: Naval Aerospace Medical Research Laboratory.
Dinges, D.F. & Kribbs, N.B. (1991). Performing while sleepy: Effects of experimentally-induced sleepiness.
In T. H. Monk (Ed.), Sleep, sleepiness and performance (pp. 97-128). Chichester: Wiley.
Englund, C.E., Ryman, D.H., Naitoh, P., & Hodgdon, J.A. (1985). Cognitive performance during successive
sustained physical work episodes. Behavior Research Methods, Instruments, &Computers, 17, 75-85.
Froberg, J., Karlsson, C.G., Levi, L., & Lidberg, L. (1972). Circadian variations in performance,
psychological ratings, catecholamine excretion and urine flow during prolonged sleep deprivation. In
W.P. Colquhoun (Ed.), Aspects of human efficiency (pp. 247.260). Cambridge, England: English
Universities Press, Ltd.
12
Glaeser, B.S., Melamed, E., Growdon, J.H., & Wurtman, R.J. (1979). Elevation of plasma tyrosine after a
single oral dose of 1-tyrosine. Life Sciences, 25, 265-272.
Gopher, D. & Kahneman, D. (1971). Individual differences in attention and the prediction of flight criteria.
Perceptual and Motor Skills, 33, 1335 1342.
Hart, J., & Wallace, J. (1975). The adverse effects of amphetamines. Clinical Toxicology, 8, 179-190.
Hartmann, E., & Cravens, J. (1976). Sleep: Effects of d- and I-amphetamine in man and in the rat.
Psychopharmacology, 50, 171-175.
Hockey, G.R.J. (1986). Changes in operator efficiency as a function of environmental stress, fatigue, and
circadian rhythms. In K.R. Boff, L. Kaufman, & J.P. Thomas (Eds.), Handbook of perception and
human performance (pp. 44-1 to 44-49). New York: Wiley.
Hoddes, E., Dement, W.C., & Zarcone, V. (1971). The development and use of the Stanford Sleepiness Scale
(SSS). Psychophysiology, 9, 150.
Hoddes, E., Zarcone, V., Smythe, H., Phillips, R., & Dement, W.C. (1973). Quantification of sleepiness: A
new approach. Psychophysiology, 10, 431-435.
Holding, D.H. (1983). Fatigue. In R. Hockey (Ed.), Stress and fatigue In human performance (pp. 145-167).
New York: Wiley.
Huynh, H., & Feldt, L.S. (1976). Estimation of the box correction for degrees of freedom from sample data in
randomized block and split-plot designs. Journal of Educational Statistics, 1, 69-82.
Johnson, L.C. (1982). Sleep deprivation and performance. In W.B. Webb (Ed.), Biological rhythms, sleep, and
performance (pp. 111-140). New York: Wiley.
Johnson, L.C., Spinweber, C.L., Gomez, S.A., & Matteson, L.T. (1989). Daytime sleepiness, performance,
mood, nocturnal sleep: The effect of benzodiazepine and caffeine on their relationship (Rel-ort No.
89-7). San Die~go: Naval Health Research Center.
Kelly, T.L., Smith, D., & Naitoh, P. (1989). Melatonin, light and circadian cycles (Report No. 89-38), San
Diego: Naval Health Research Center.
Kjellberg, A. (1977). Sleep deprivation and some aspects of performance. II. Lapses and othor attentional
effects. Waking and Sleeping, 1, 145-148.
Lieberman, H.R., Corkin, S., Spring, B.J., Growdon, J.H., & Wurtman, R.J. (1983). Mood, performance and
pain sensitivity: Changes induced by food constituents. Journal of Psychiatric Research, 17, 135-145.
Lieberman, H.R., Corkin, S., Spring, B.J., Wurtman, R.J., & Growdon, J.H. (1985). The effects of dietary
neurotransmitter precursors cn human behavior. American Journal of Clinical Nutrition, 42, 366-370.
Lisper, H.-O., & Kjellberg, A. (1972). Effects of 24-hour sleep deprivation on rate of decrement in a 10-
minute auditory reaction time task. Journal of Experimental Psychology, 96, 287-290.
Monk, T.H., & Folkard, S. (1992). Making shift work tolerable. London: Taylor & Francis.
13
Mullaney, D.J., Kripke, D.F., Fleck, P.A., & Johnson, L.C. (1983). Sleep loss and nap effects on sustained
continuous performance. Psychophysiology, 20, 643-651.
Naitoh, P., & Kelly, T.L. (1992). Sleep management user's guide for special operations personnel (Report No.
92-28). San Diego: Naval Health Research Center.
Newhouse, P.A., Belenky, G., Thomas, M., Thorne, D., Sing, G.C., & Fertig, J. (1989). The effects of
d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation.
Neuropsychopharmacology, 2, 153-164.
Newhouse, P.A., Penetar, D.M., Fertig, J.B., Thome, D.R., Sing, H.C., Thomas, M.L., Cochran, J.C., &
Belenky, G.L. (1992). Stimulant drug effects on performance and behavior after prolonged sleep
deprivation: A comparison of amphetamine, nicotine, and deprenyl. Military Psychology, 4, 207-233.
Owasoyo, J.O., Neid, D.F., & Lamberth, J.G. (1992). Tyrosine and its potential use as a countermeasure to
performance decrement in military sustained operations. Aviation, Space, and Envi'onmental Medicine,
63, 364-369.
Patrick, G.T.W., & Gilbert, J.A. (1896). On the effects of loss of sleep. Psychological Review, 3, 469-483.
Penetar, D.M., Sing, H.C., Thorne, D.R., Thomas, M.L., Fertig, J.B., Schelling, A.S.D., Sealock, J.C.,
Newhouse, P.A., & Belenky, G. (1991). Amphetamine effects on recovery sleep following total sleep
deprivation. Human Psychopharmacology, 6, 319-323.
Rosvold, H.E., Mirsky, A.F., Sarason, I., Bransome, E.D., & Beck, L.H. (1956). A continuous performance
test of brain damage. Journal of Consulting and Clinical Psychology, 20, 343-350.
Salter, C.A. (1989). Dietary tyrosine as an aid to stress resistance among troops. Military Medicine, 154,
144-146.
Shappell, S.A., Neri, D.F., & DeJohn, C.A. (1992). Simulated sustained flight operations and performance. II.
Effects of dentro-methamphetamine. Military Psychology, 4, 267-287.
Shurtleff, D., Thomas, J.R., Ahlers, S.T., & Schrot, 1. (1999). Tyrosine ameliorates a cold-induced delayed
matching-to-sample performance decrement in ,ats. Psychopharmacology, 112, 228-232.
Shurtleff, D., Thomas, J.R., Schrot, J., Kowalski, K., & Harford, R. (1994). Tyrosine reverses a cold-induced
working memory deficit in humans. Pharmacology, Biochemistry, and Behavior, 45, 1-7.
Stanny, R.R., McCardie, A.H., & Neri, D.F. (1993a). Effects of methamphetamine andfatigLe on long- and
short-term memory (Report No. 1387). Pensacola, FL: Naval Aerospace Medical Research Laboratory.
Stanny, R.R., McCardie, A.H., & Neri, D.F. (1993b). Effects of methamphetamine on vigilance and tracking
during extended wakefulness (Report No. 1386). Pensacola, FL: Naval Aerospace Medical Research
Laboratory.
Stone, E.A. (1975). Stress and catecholamines. In A.J. Friedhoff (Ed.), Catecholamnines and behavior (pp.
31-72). New York: Plenum Press.
Tharp, V.K. (1978). Sleep loss and stages of information processing. Waking and Sleeping, 2, 29-33.
14
Tilley, A., & Brown, S. (1992). Sleep deprivation. In A.P. Smith & D.M. Jones (Eds.), Handbook of human
performance. Vol. 3. State and trait (pp. 237-259). London: Academic Press.
Warren, N., & Clark, B. (1937). Blocking in mental and motor tasks during a 65-hour vigil. Journal of
Experimental Psychology, 21, 97-105.
Williams, H.L., Lubin, A., & Goodnow, J.J. (1959). Impaired performance with acute sleep loss.
Psychological Monographs, 73, 1-26,
Wurtman, R.J. (1982). Nutrients that modify brain function, Scientific American, 246, 50-59.
Wurtman, R.J. (1986). Use of tyrosine and other nutrients to enhance and sustain performance. In Proceedings
of the AGARD Aerospace Medical Panel Symposium, biochemical enhancement of performance, Lisbon,
Portugal, Sep 30-Oct 2 (pp. 1-4). Neuilly-Sur-Seine, France: NATO.
Wurtman, R.J., Hefti, F., & Melamed, E. (1981). Precursor control of neurotransmitter synthesis.
Pharmacological Reviews, 32, 315-335.
15
Other Related NAMRL Publications2
DeJohn, C. A., & Reams, G. G. (1992). An analysis of a sustained flight operation training mission in Navy
attack aircraft (Report No. 1370). Pensacola, FL: Naval Aerospace Medical Research Laboratory.
(AD A258 199)
DeJohn, C. A., Shappell, S. A., & Ned, D. F. (1992). Effects of dextromethamphetamine on subjective fatigue
(Report No. 1376). Pensacola, FL: Naval Aerospace Medical Research Laboratory. (AD A258 252)
DeJohn, C. A., Shappell, S. A., & Nefi, D. F. (1992). Subjective fatigue in A-6, F-14, and F/A-18 aircrews
during Operations Desert Shield and Desert Storm (Report No. 1377). Pensacola, FL: Naval Aerospace
Medical Research Laboratory. (AD A259 243)
Nedi, D. F., & Shappell, S. A. (1992). The effect of combat on the work/rest schedules and fatigue of A-6 and
F-14 aviators during Operation Desert Shield/Storm (Report No. 1375). Pensacola, FL: Naval
Aerospace Medical Research Laboratory. (AD A258 146)
Nerd, D. F., & Shappell, S. A. (1993). Work/rest schedules and performance of S-3 aviators during Fleet Exer-
cise 1992 (Report No. 1382). Pensacola, FL: Naval Aerospace Medical Research Laboratory.
(AD A265 807)
Neri, D. F., & Shappell, S. A. (In press). The effect of combat on the work/rest schedules and fatigue of A-6
and F-14 aviators during Operation Desert Shield/Storm. Military Psychology.
Ned, D. F., Shappell, S. A., & DeJohn, C. A. (1992). Simulated sustained flight operations and performance,
Part 1: Effects of fatigue. Military Psychology, 4, 137-155. (AD A261 012)
Owasoyo, .. 0., Ned, D. F., & Lamberth, J. G. (1992). Tyrosine and its potential use as a countermeasure to
performance decrement in military sustained operations. Aviation, Space, and Environmental Medicine,
63, 364-369. (AD A253 515)
Shappell, S. A., & Neff, D. F, (1993). Effect of combat on aircrew subjective readiness during Operation
Desert Shield/Storm. The International Jourtal of Aviation Psychology, 3, 231-252.
Shappell, S. A., & Ned, D. F. (1992). The effect of :zombat on aircrew subjective readiness and LSO grades
during Operation Desert Shield/Storn (Report No. 1369). Pensaccla, FL: Naval Aerospace Medical
Research Laboratory. (AD A254 841)
Shappell, S. A., & Neri, D. F. (1993). Work/rest schedules and performance of F/A-18 aviators during Fleet
Exercise 1992 (Report No. 1383). Pensacola, FL: Naval Aerospace Medical Research Latioratory. (AD
A265 826)
'Publications with AD numbers are available from the Defense Technical Information Center, Cameron
Station, Alexandria, VA 22314-6145, (202) 274-7633.
16
APPENDIX A
Visual Analog Scale Items
Fluttering Heart
Dizzy
Ill at ease
Euphoric (feeling that all is well)
Overstimulated
Restless
Shaky
Headache
Diarrhea
Constipated
Abdominal Cramps
Dry mouth
Unpleasant Taste
Itchy
Fatigued
Depressed
Anxious
Hostile
Jumpy
Talkative
Hurgry
Difficulty urinating
Urinating frequently
Sleepy
Rapid breathing
Alert
Able to focus attention
Bored
A-I
APPENDIX B
Stanford Sleepiness Scale
1. Feeling active and vital; alert; wide awake
2. Functioning at a high level, but not at peak; able to concentrata
3. Relaxed; awake; not at full alertness; responsive
4. A little foggy; not at peak; let down
5. Fogginess; beginning to lose interest in remaining awake; slowed down
6. Sleepiness; prefer to be lying down; fighting sleep; woozy
7. Almost in reverie, sleep onset soon; lost struggle to remain awake
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